|
Parameters
|
Overall
|
According to the IOM mass index
|
|---|
|
Low IOM
|
High IOM
|
p-value
|
|---|
|
Number
|
222
|
111
|
111
| |
|
Age (years)
|
67.82 ± 6.23
|
68.55 ± 6.11
|
67.10 ± 6.29
|
0.083
|
|
IOM (mm2/cm2)
|
11.23 ± 2.22
| | | |
|
BMI (kg/m2)
|
24.46 ± 2.86
|
24.17 ± 2.86
|
24.74 ± 2.85
|
0.136
|
|
Pre-op PSA (ng/mL)
|
11.61 ± 13.22
|
11.12 ± 12.29
|
12.11 ± 14.12
|
0.579
|
|
Prostate volume (cc)
|
34.58 ± 14.13
|
35.56 ± 15.68
|
33.57 ± 12.33
|
0.313
|
|
Type of operation
| | | |
0.200
|
|
RRP
|
163 (73.4)
|
77 (69.4)
|
86 (77.5)
| |
|
LRP
|
1 (0.5)
|
0
|
1 (0.9)
| |
|
RARP
|
58 (26.1)
|
34 (30.6)
|
24 (21.6)
| |
|
Gleason score
| | | |
0.441
|
|
≤ 6
|
59 (26.6)
|
24 (21.6)
|
35 (26.6)
| |
|
7
|
145 (65.3)
|
78 (70.3)
|
67 (65.3)
| |
|
8
|
8 (3.6)
|
4 (3.6)
|
4 (3.6)
| |
|
9
|
10 (4.5)
|
5 (4.5)
|
5 (4.5)
| |
|
T-stage
| | | |
0.717
|
|
T2a
|
28 (12.6)
|
14 (12.6)
|
14 (12.6)
| |
|
T2b
|
38 (17.1)
|
19 (17.1)
|
19 (17.1)
| |
|
T2c
|
119 (53.6)
|
56 (50.5)
|
63 (56.8)
| |
|
T3a
|
21 (9.5)
|
13 (11.7)
|
8 (7.2)
| |
|
T3b
|
16 (7.2)
|
9 (8.1)
|
7 (6.3)
| |
|
N-stage
| | | |
0.155
|
|
0
|
267 (97.1)
|
111 (100)
|
109 (98.2)
| |
|
1
|
8 (2.9)
|
0 (0.0)
|
2 (1.8)
| |
|
cM stage
| | | |
0.316
|
|
0
|
221 (99.5)
|
110 (99.1)
|
111 (100)
| |
|
1
|
1 (0.5)
|
1 (0.9)
|
0 (0.0)
| |
|
BCR
| | | |
0.871
|
|
0
|
173 (77.9)
|
87 (78.4)
|
86 (77.5)
| |
|
1
|
49 (22.1)
|
24 (21.6)
|
25 (22.5)
| |
- BMI, body mass index; pre-op PSA, pre-operative prostate-specific antigen; RRP, radical retropubic prostatectomy; LRP, laparoscopic radical prostatectomy; RARP, robot-assisted radical prostatectomy; BCR, biochemical recurrence
